Sanofi-Aventis Deutschland GmbH — FDA Facility Profile

FEI 3003195501

Sanofi-Aventis Deutschland GmbH is an FDA-registered facility (FEI 3003195501) located in Frankfurt am Main, DE. Registered operations: ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK. RegDataLab tracks 11 FDA inspections and 1 compliance action at this facility.

Reviewing Sanofi-Aventis Deutschland GmbH as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Sanofi-Aventis Deutschland GmbH yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Mar 25, 2022: Voluntary Action Indicated (VAI)
Inspections on record
11 (1 OAI, 7 VAI, 3 NAI)
Last OAI inspection
Sep 16, 2010
Warning letters
1 listed by FDA for this FEI, latest Feb 8, 2011
Form 483 and inspection documents
1 in FDA's reading room
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 11 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 25, 2022Voluntary Action Indicated (VAI)No citations listed
May 14, 2019Voluntary Action Indicated (VAI)No citations listed
Mar 3, 2017Voluntary Action Indicated (VAI)Equipment to control conditions (21 CFR 211.42(c)(10)(vi))
Validation lacking for sterile drug products (21 CFR 211.113(b))
Establish reliability of supplier's C of A (21 CFR 211.84(d)(2))
Written record of investigation incomplete (21 CFR 211.192)
Dec 10, 2015No Action Indicated (NAI)Management review - defined interval, sufficient frequency (21 CFR 820.20(c))
Jun 26, 2015Voluntary Action Indicated (VAI)No citations listed
Dec 5, 2013No Action Indicated (NAI)No citations listed
Jul 2, 2013Voluntary Action Indicated (VAI)No citations listed
Apr 30, 2012No Action Indicated (NAI)No citations listed
Jul 14, 2011Voluntary Action Indicated (VAI)No citations listed
Sep 16, 2010Official Action Indicated (OAI)No citations listed

Form 483s and inspection documents

Facility details

Company
Sanofi-Aventis Deutschland GmbH
Location
Frankfurt am Main (DE)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.